Article Text

Download PDFPDF
Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention
  1. Gen-Min Lin1,
  2. Yi-Hwei Li2,
  3. Kai-Min Chu3,
  4. Chih-Lu Han4
  1. 1Hualien-Armed Forces General Hospital, Department of Medicine, Hualien, Taiwan, China
  2. 2Department of Public Health, Tzu-Chi University, Hualien, Taiwan
  3. 3Division of Cardiology, Tri-service General Hospital, Taipei, Taiwan
  4. 4Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  1. Correspondence to Dr Gen-Min Lin, Hualien-Armed Forces General Hospital, Department of Medicine, No.163, Jiali Rd., Xincheng Township, Hualien, Taiwan 971, China; farmer507{at}

Statistics from

To the Editor We read with interest the meta-analysis by Siller-Matula et al, which reported that intensified clopidogrel loading with 600 mg reduces the rate of major cardiovascular events without increase in major bleeding compared with 300 mg in patients undergoing percutaneous coronary intervention (PCI) during 1-month follow-up.1 A large body of evidence has suggested the effectiveness and safety of the 600 mg loading dose of clopidogrel for patients with acute coronary syndrome undergoing primary PCI. Besides, many experts indicated that the benefits of additional antiplatelet agents were mainly for those with high-risk profiles and advanced Killip's classifications.2 Accordingly, the authors raised a critical concern …

View Full Text


  • Linked articles 300252.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • PostScript
    Jolanta M Siller-Matula Bernd Jilma